Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2021-11-15 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces a specific operational milestone: the first implantation of the Aeson® artificial heart in the Netherlands. It includes quotes from management and details about the procedure and the study (PIVOT). This format—a brief, timely announcement of a significant event or result, often released before a full financial report—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is not a full quarterly/annual report (IR/10-K), a transcript (CT), or a presentation (IP), and it is a specific, material operational update, it fits best as an Earnings Release (ER) if it were tied to a reporting period, or more generally, a Regulatory Filing (RNS) if it's purely operational news. Given the content is a major operational/clinical update rather than just financial highlights, and it is a press release format, it strongly aligns with a general regulatory announcement or news release. However, in the context of financial filings, major operational news that impacts investor perception is often categorized under the closest relevant type. Since it is a formal announcement of a significant event, and not a standard financial report, 'RNS' (Regulatory Filings/General Announcement) is the most appropriate fallback, although 'ER' often captures significant operational news released outside of formal quarterly reporting cycles. Given the structure and purpose (announcing a key event), I will classify it as a general Regulatory Filing (RNS) as it is a press release detailing a clinical/operational achievement, which is a common type of filing under RNS when other specific categories don't apply.
2021-11-15 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces that the Aeson® artificial heart was presented at a web conference hosted by an investment bank. It provides details about the conference, speakers, and a link to the replay. This structure—a brief announcement about an event (a presentation/call) and providing access to the content—is characteristic of a communication intended to inform investors and the public about recent activities. Since it is not the full transcript of the call (CT), nor a formal regulatory filing like a 10-K or IR, and it is essentially an announcement of an investor-focused event, it aligns best with a general announcement or a type of investor communication. Given the options, it is a press release about an event, which often falls under general regulatory announcements or investor relations material. Since it is not a formal Earnings Release (ER) or a detailed Investor Presentation (IP), and it is a general announcement, the most fitting category is Regulatory Filings (RNS) as a catch-all for press releases that don't fit elsewhere, or potentially a type of Investor Presentation (IP) if the web conference content was highly detailed. However, the text itself is the announcement *of* the presentation, not the presentation slides or the full transcript. Because it is a press release announcing an event where company information was shared, and it doesn't fit the specific definitions of ER, IP, or CT, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback classification for a corporate press release of this nature.
2021-10-21 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces that the company's artificial heart product (Aeson®) was presented during a webcast organized by an investment bank (Ladenburg Thalmann). It details the participants of the webcast and provides a link to the recording. This format—a brief announcement about an event or presentation, often including contact information for press/investors, and explicitly linking to external content—strongly suggests it is an announcement rather than a full financial report (like 10-K or IR) or a transcript of the event itself (CT). Since it is an announcement related to investor relations and corporate activity, and it is not a standard regulatory filing like a 10-K or a specific report type, it fits best under the general category for regulatory announcements or press releases that don't fit elsewhere, which is RNS (Regulatory Filings/Miscellaneous Announcements). However, given the content is specifically about an investor/analyst event, it could also be argued as an Investor Presentation (IP) if the webcast content was the presentation itself, but the document *is* the press release *about* the webcast. Following Rule 2 (Menu vs Meal), since this is a short announcement about a presentation, and not the presentation itself, RPA or RNS is more appropriate. RPA is for announcing the *publication* of a report. This is announcing participation in an event. Therefore, RNS (Regulatory Filings/Miscellaneous) is the most appropriate fallback for a general press release about corporate/investor activity not covered by other specific codes.
2021-10-21 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the publication of a scientific article regarding the company's product (Aeson®) in the ASAIO Journal. It contains key highlights, management commentary, company background, and contact information, which are characteristic features of an Earnings Release (ER) or a general press announcement. Since it is not a full financial report (like 10-K or IR), nor a transcript (CT), nor a specific regulatory filing like DIRS or DIV, and it serves to disseminate important, timely news, it fits best as an Earnings Release (ER) if it were tied to a reporting period, or a general Regulatory Filing (RNS) if it's purely informational. Given the context of financial reporting databases, press releases announcing significant operational/research milestones often fall under ER if they are periodic, or RNS if they are ad-hoc. Since this is a specific announcement about a published article, and not a standard quarterly financial summary, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for non-standard, yet important, corporate news that doesn't fit the other specific categories. However, many financial databases classify press releases announcing key operational/research achievements as ERs if they are frequent. Given the structure and the fact that it's a formal announcement, I will lean towards RNS as the most general fit for non-financial-statement press releases, although ER is plausible if this was part of a quarterly cycle. Re-evaluating the definitions: ER is for 'initial announcement of quarterly/periodical financial results (key highlights only)'. This is not financial results. Therefore, RNS (General regulatory announcements and fallback category) is the correct classification for this specific type of operational/research press release.
2021-10-12 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces that CARMAT has published an article in the *ASAIO Journal* regarding its Aeson® heart system. The text focuses on communicating recent scientific/clinical findings and management commentary to the public and investors, rather than being the full financial report (10-K, IR) or a formal regulatory filing like a dividend notice or capital change. Since it is an announcement of news/results, it fits best as an Earnings Release (ER) if it were tied to financial results, or more generally as a Regulatory Filing (RNS) if it doesn't fit other specific categories. However, given the content is a scientific/clinical update presented as a press release, and it is not a formal financial report, it is most appropriately classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if we interpret 'announcement of results' broadly. Since it is a press release announcing a publication, and not a formal earnings report, RNS is the most suitable general regulatory announcement category, although it shares characteristics with an ER in terms of disseminating important company news. Given the options, and the nature of a press release announcing a scientific publication, RNS (Regulatory Filings - general regulatory announcements) is the safest fit, as it is not a specific financial report type.
2021-10-12 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate event: the first implant of CARMAT's artificial heart in a female recipient as part of a U.S. Early Feasibility Study. It contains key financial/corporate contacts, a disclaimer, and is structured to disseminate timely, material, non-financial news to the public and investors. This format strongly suggests an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a comprehensive financial report (like 10-K or IR) but rather a specific operational/clinical milestone announcement, it fits best as an Earnings Release (ER) if it were tied to a reporting period, or more generally, a Regulatory Filing (RNS) if it's purely operational news. Given the context of financial databases, press releases announcing significant operational milestones often fall under the 'ER' umbrella if they are periodic, or 'RNS' if they are ad-hoc. Since this is a specific, material operational update, and not a standard quarterly financial summary, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for non-standard news, although ER is often used for press releases. However, looking at the definitions, ER is for 'initial announcement of quarterly/periodical financial results (key highlights only)'. This is not financial results. Therefore, RNS (Regulatory Filings/General Announcement) is the most suitable category for this material, non-financial press release.
2021-09-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.